China Chamber of Commerce for Import & Export of Medicines & Health (CCCMHPIE) and Diapharm GmbH & Co. KG have reached a co-operation agreement in order to bring high quality pharmaceutical consulting services including EU market access, MA licensing etc. to Chinese companies. A signing ceremony will be held at CPhI China to endorse the joint move that will bring more high quality Chinese medicines to the EU market.
Founded in 1988, Diapharm is a leading global service provider and consulting firm for the consumer healthcare and pharmaceutical industry. Diapharm supports clients in the fields of medicinal products, medical devices, food supplements, dietetic foods and cosmetics. The company focuses on services like regulatory affairs and marketing authorisation, medical and scientific tasks, quality assurance and consulting. Headquartered in Germany, Diapharm’s team of experts will lead Chinese companies to the European market safely and successfully. Diapharm has already successfully helped achieve several marketing authorisations for the first TCM product in Europe. Besides, Diapharm has more than 100 marketing application dossiers on medicinal products and medical devices available and the company is now seeking for co-operative partners in China.
CCCMHPIE, a social organisation with the status of a legal person which was founded in May 1989, is the leading and most influential national trade chamber in China with a mission to promote the international trade and cooperation in medicinal and health products. In the regulatory affairs, CCCMPHIE maintains good relationships with international and domestic regualtory authorities and industry associations. We provide market information and pharmaceutical regulations information to local and overseas enterprises. CCCMHPIE，directly under the Ministry of Commerce of China, has a diverse membership of more than 2,400 companies including major manufacturers and trading companies of pharmaceutical and health products.